E-mail a Wiley Online Library Link

J. Fowler, M. Jarratt, A. Moore, K. Meadows, A. Pollack, M. Steinhoff, Y. Liu, M. Leoni and on behalf of the Brimonidine Phase II Study Group Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies British Journal of Dermatology 166

Version of Record online: 22 FEB 2012 | DOI: 10.1111/j.1365-2133.2011.10716.x

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field